Aytu Biopharma (AYTU) Inventory Average (2015 - 2026)

Aytu Biopharma (AYTU) has 12 years of Inventory Average data on file, last reported at $8.1 million in Q1 2026.

• On a quarterly basis, Inventory Average fell 27.22% year-over-year to $8.1 million in Q1 2026; TTM through Mar 2026 was $8.1 million, a 27.22% decrease from a year earlier, with the FY2025 full-year figure at $11.8 million, down 2.32% from the prior year.
• Inventory Average for Q1 2026 stood at $8.1 million, down from $9.4 million in the prior quarter.
• Over the last five years, Inventory Average for AYTU reached as high as $15.2 million in Q1 2022 and fell as low as $8.1 million in Q1 2026.
• Historically, Inventory Average has averaged $12.0 million across 5 years, with a median of $12.4 million in 2022.
• Across the five-year window, Inventory Average slipped 27.36% in 2022 and grew 5.23% in 2023, its largest moves.
• Year by year, Inventory Average stood at $12.9 million in 2022, then rose by 0.57% to $13.0 million in 2023, then declined by 12.1% to $11.4 million in 2024, then fell by 17.82% to $9.4 million in 2025, then declined by 14.08% to $8.1 million in 2026.
• Per Business Quant data, the three most recent Inventory Average figures were $8.1 million in Q1 2026, $9.4 million in Q4 2025, and $10.8 million in Q3 2025.